Role of locoregional surgery in patients with de novo stage IV breast cancer: analysis of real-world data from China
| Autor: | Li Ma, Haiqing Zhang, Shude Cui, Cuizhi Geng, Feng Jin, Yongmei Yin, Peifen Fu, Jianbin Li, Zefei Jiang, Haibo Wang, Yunzhe Mi, Yin-Hua Liu, Zhimin Fan |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Adult
medicine.medical_specialty China Receptor ErbB-2 lcsh:Medicine Bone Neoplasms Breast Neoplasms Article 03 medical and health sciences Young Adult 0302 clinical medicine Breast cancer medicine Humans In patient 030212 general & internal medicine lcsh:Science Triple-negative breast cancer Survival analysis Aged Retrospective Studies Aged 80 and over Multidisciplinary business.industry lcsh:R Small tumours Middle Aged medicine.disease Prognosis Metastatic breast cancer Surgery Survival Rate Receptors Estrogen 030220 oncology & carcinogenesis Lymphatic Metastasis Tumour immunology Female lcsh:Q Neoplasm Recurrence Local Stage iv business Receptors Progesterone Real world data Follow-Up Studies |
| Zdroj: | Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020) Scientific Reports |
| ISSN: | 2045-2322 |
| DOI: | 10.1038/s41598-020-75119-0 |
| Popis: | Stage IV breast cancer is metastatic breast cancer (MBC). Because real-world data are lacking in China, our research attempts to explore the effect of locoregional surgery on the prognosis of patients with MBC. A total of 987 patients from 10 hospitals and 2 databases in East China (2004–2018) were included in this study. Overall, 47% of patients underwent locoregional surgery, and 53% did not. Surgeons tended to perform surgery on patients with small tumours (T1/T2), positive hormone receptor (HR) markers, and metastatic sites confined to a single organ and non-visceral sites (bone only/others) (each p p p p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |